Keith Michael Gottesdiener

Filings by Keith Michael Gottesdiener span 2 companies, the busiest being Intercept Pharmaceuticals, Inc. and Prime Medicine, Inc. Over a trading history stretching from 27 May 2021 to 8 October 2024, the count stands at 7 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 10 October 2024 came the latest disclosure, a transaction in Prime Medicine, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.